Voso MT

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.

Voso MT, Pandzic T, Falconi G, ..., Fabiani E, Baliakas P

Br. J. Haematol. 198 (1) 103-113 [2022-07-00; online 2022-03-11]

Clinical Genomics Uppsala [Service]

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Bernard E, Nannya Y, Hasserjian RP, ..., Ogawa S, Papaemmanuil E

Nat. Med. 26 (10) 1549-1556 [2020-10-00; online 2020-08-03]

Clinical Genomics Uppsala [Service]